Delisting riskPopularity #4,507
CVM · AMEX · Biotechnology

CEL-SCI (CVM)

Develops a pre-surgical cytokine treatment for selected head-and-neck cancer patients.

$1.71
vs last close+0.01 (+0.59%)
  1. CEL-SCI Issues Letter to Shareholders

    Business Wire